CSIMarket


Teva Pharmaceutical Industries Ltd  (TEVA)
Other Ticker:  
 

Teva Pharmaceutical Industries Ltd

TEVA's Fundamental analysis






Teva Pharmaceutical Industries Ltd's sales fell by -10.75 % in II. Quarter 2020 from the same quarter a year ago. Ranking at No. 1895

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -8 %

Teva Pharmaceutical Industries Ltd realized net income compared to net loss a year ago in II. Quarter 2020

More on TEVA's Growth


Teva Pharmaceutical Industries Ltd
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Teva Pharmaceutical Industries Ltd PEG ratio is at -1.5438339522626E+15 Company is currently trading with Price to Cash flow multiple of 15.2 in trailing twelve-month period.
Company
1.5438339522626E+17
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.57.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.47.

Teva Pharmaceutical Industries Ltd Price to Book Ratio is at 0.64 lower than Indusry Avg. of 1715.51. and higher than S&P 500 Avg. of -0.01

More on TEVA's Valuation
 
 Total Debt (Millions $) 26,265
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 3.19
 Tangible Book Value (Per Share $) -17.94

Teva Pharmaceutical Industries Ltd
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Teva Pharmaceutical Industries Ltd PEG ratio is at -1.5438339522626E+15 Company is currently trading with Price to Cash flow multiple of 15.2 in trailing twelve-month period.
Company
1.5438339522626E+17
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.57.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.47.

Teva Pharmaceutical Industries Ltd Price to Book Ratio is at 0.64 lower than Indusry Avg. of 1715.51. and higher than S&P 500 Avg. of -0.01

More on TEVA's Valuation

 Market Capitalization (Millions $) 9,427
 Shares Outstanding (Millions) 1,100
 Employees -
 Revenues (TTM) (Millions $) 16,483
 Net Income (TTM) (Millions $) -154
 Cash Flow (TTM) (Millions $) 620
 Capital Exp. (TTM) (Millions $) -547
 Total Debt (Millions $) 26,265
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover Ratio (TTM) 3.19
 Tangible Book Value (Per Share $) -17.94

 Market Capitalization (Millions $) 9,427
 Shares Outstanding (Millions) 1,100
 Employees -
 Revenues (TTM) (Millions $) 16,483
 Net Income (TTM) (Millions $) -154
 Cash Flow (TTM) (Millions $) 620
 Capital Exp. (TTM) (Millions $) -547

TEVA's Profitability Comparisons
Teva Pharmaceutical Industries Ltd achieved increase in profitability, decrease in demand. Operating Margin grew in II. Quarter 2020 to 4.47 % from 4.38 % in I. Quarter.

Teva Pharmaceutical Industries Ltd net profit margin of 1.37 % is currently ranking no. 49 in Major Pharmaceutical Preparations industry, ranking no. 152 in Healthcare sector and number 1963 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 1.09
  Total Debt to Equity (MRQ) 1.77
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.29
  Inventory Turnover Ratio (TTM) 2



Teva Pharmaceutical Industries Ltd achieved increase in profitability, decrease in demand. Operating Margin grew in II. Quarter 2020 to 4.47 % from 4.38 % in I. Quarter.

Teva Pharmaceutical Industries Ltd net profit margin of 1.37 % is currently ranking no. 49 in Major Pharmaceutical Preparations industry, ranking no. 152 in Healthcare sector and number 1963 in S&P 500.

More on TEVA's Key Ratios





       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TTNP's Profile

Stock Price

TTNP's Financials

Business Description

Fundamentals

Charts & Quotes

TTNP's News

Suppliers

TTNP's Competitors

Customers & Markets

Economic Indicators

TTNP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071